Click here to load reader
Upload
haanh
View
212
Download
0
Embed Size (px)
Citation preview
MEDIA RELEASE 21 APRIL 2010
Research in infectious diseases and immunology receive shot in the arm with fresh funding
1. Twelve research projects on infectious diseases and immunology have been awarded grants by A*STAR’s Biomedical Research Council (BMRC) and Singapore Immunology Network (SIgN) this year. Helmed by researchers from local universities, research institutes and hospitals, these projects account for over one-third of the $23 million in grants from BMRC’s 8th General Grant Call and SIgN’s 4th Grant Call aimed at supporting the translation of lab discoveries to potential clinical therapies for diseases prevalent in Singapore and the region.
Of viral infections and the human immune response
2. Eight projects will examine viral infections and the human immune response. The results of which will potentially lead to better vaccines and improved clinical care for patients. One of the projects is led by Assistant Prof Toh Chee Seng of the National University of Singapore (NUS), who, in close collaboration with dengue and antibody research experts from A*STAR’s SIgN, is developing an ultra-sensitive, low cost biosensor probe system for fast detection of the dengue1 virus. The system comprises a channel of nanometre-scale attached with antibodies that can bind and distinguish between the four serotypes of the dengue virus, as well as a detector.
3. “With this system, we will be able to sense low amounts of the dengue virus in patients’ blood samples, and thus reduce the time needed for analysis from the current six hours to less than one hour. If successful, this system may also be further applied to rapid detection of multiple diseases at clinics, schools and offices during large-scale outbreaks of infectious diseases,” said Assistant Prof Toh.
4. Another project led by Dr Justin Chu from NUS is seeking to answer important questions on the pathogenesis of the chikungunya virus, particularly about how its receptors function and how it enters cells. “This mosquito-borne virus was
1 Dengue fever, together with the associated dengue haemorrhagic fever, is endemic throughout
tropical countries including Singapore, and is the world’s fastest growing vector-borne disease. Globally, there are an estimated 100 million cases of dengue fever annually, 250,000 cases of dengue haemorrhagic fever and an annual mortality rate of 25,000. In Singapore, swift implementation of vector control measures brought the disease, which had caused an epidemic in the 1960s, under control. However, after a lapse of 3 decades, dengue returned to Singapore in the 1990s. Close to 15,000 cases and 25 dengue deaths were reported during an outbreak in 2005.
responsible for a local outbreak in 2008 and is fast becoming a global threat,” said Dr Chu. “It is therefore critical for scientists to develop a good understanding of the complex virus-host interactions, so as to provide the basis for the development of possible therapeutics or vaccines against related viral infections. We hope that our research will ultimately contribute towards better diagnosis and treatment for patients,” he added.
5. The research project on anterior uveitis, a specific form of inflammation of the eye for which the cause remains unknown, is led by Associate Prof Chee Soon Phaik from the Singapore National Eye Centre, in collaboration with Dr Subhra Biswas from SIgN. The team will study the role of the cytomegalovirus (CMV) in anterior uveitis and other eye diseases. CMV, which can infect people of all ages, sexes and ethnic backgrounds, can remain in the body after infection and be reactivated upon subsequent stress to the immune system. It can also be transmitted from mother to baby. Said Assoc Prof Chee, “We have made some early breakthroughs in research on CMV-associated uveitis. Building upon these earlier findings, we aim to use the current research to contribute to improved diagnosis and better management of the disease.”
6. Prof Sir George Radda, Chairman of BMRC, said, “BMRC's General Grant Call provides funding to the most promising of grant applications, which aim to unveil new knowledge, create breakthroughs in biomedical science, and advance translational and clinical research. Funding such research is core to A*STAR's mission and purpose to create industrial advances, economic benefits and better health for all. We are pleased with the quality of the 2009 applications and hope that the scientific community in Singapore will continue to work together to pursue high-impact and meaningful outcomes for society.”
7. Said Prof Paola Castagnoli, Scientific Director of SIgN, “The 2009 SIgN grants were awarded to deserving clinical researchers who, in addition to having original ideas for addressing fundamental clinical problems, demonstrate strong partnerships with scientists who could share relevant skills and knowledge to fulfill common research goals. As Singapore ramps up its efforts in bench-to-bedside translational research, SIgN will continue to contribute to the vibrant research environment here by encouraging the exchange of ideas and expertise between academic, industrial and clinical partners.”
Minding heart and mental health
8. In addition to the research projects on infectious diseases and immunology, grants were also awarded by BMRC to novel research in neuroscience and cardiovascular disease, which could be applied to address pressing health issues in Singapore such as heart disease2 and depression3. A total of 30 projects (a list of 2 Worldwide, 7.2 million or 12.2% of the population die from coronary heart disease each year, a
figure that the World Health Organisation (WHO) expects to increase, especially in the Southeast Asian region. According to the Singapore Heart Foundation, death from cardiovascular disease (including heart disease and stroke) accounted for 32.5% or one in three of all deaths in Singapore, and was second only to cancer.
3 Depression is a serious and debilitating disorder affecting up to 8% of the population in Singapore
and worldwide. Currently available treatments often have significant side-effects, and not all patients
respond to therapy.
the projects is provided in the Annex A) were awarded grants under BMRC’s 8th General Grant Call and SIgN’s 2009 Collaborative Grant Call.
Background
9. Since its inaugural General Grant Call in 2001, BMRC has awarded a total of 414 grants (amounting to over $306 million) to local research institutes and hospitals including NNI, NUS, NTU, Duke-NUS GMS, NUH and NCCS to realise the vision of developing Singapore as a leading hub of biomedical research and development. The 9th BMRC General Grant Call is expected to open for applications on 3 May this year. SIgN has awarded grants to support 26 projects in the field of immunology since its inception in 2006. The SIgN 5th Grant Call is expected to open for applications in July this year.
___________________________________________________________________ Agency for Science, Technology and Research (A*STAR) For media queries, please contact: Wang Yunshi Corporate Communications Agency for Science, Technology and Research (A*STAR) DID: +65 6826 6443 Email: [email protected]
About the Agency for Science, Technology and Research (A*STAR)
A*STAR is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. A*STAR oversees 14 biomedical sciences, and physical sciences and engineering research institutes, and nine consortia & centres, which are located in Biopolis and Fusionopolis, as well as their immediate vicinity.
A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, hospitals, research centres, and with other local and international partners.
A*STAR’s Biomedical Research Council (BMRC) oversees the development of core research capabilities within A*STAR research units specialising in bioprocessing; chemical synthesis; genomics and proteomics; molecular and cell biology; bioengineering and nanotechnology and computational biology. Through competitive grants, the Council also supports research in the wider scientific community such as public universities and hospitals. As part of its efforts to advance human healthcare, BMRC actively promotes translational medicine and cross-disciplinary research. The Council also engages in human capital development in the biomedical sciences and promotes societal awareness of biomedical research through outreach programmes.
For more information on A*STAR, please visit www.a-star.edu.sg.
About the Singapore Immunology Network (SIgN)
SIgN, officially inaugurated on 15 January 2008, is a research consortium under A*STAR's Biomedical Research Council. It is aimed at building on the strengths of the existing immunology research groups at A*STAR, as well as expanding and strengthening the immunology research expertise in Singapore. SIgN's objectives include coordinating basic, translational and clinical research needed to establish immunology as a core capability in Singapore. The major focus areas of research at SIgN are Infection and Inflammation, in which SIgN researchers investigate immune responses and regulation in disease-specific contexts. Through this, SIgN aims to build up a strong platform in basic human immunology research for better translation of research findings into clinical applications. SIgN also sets out to establish productive links with local initiatives within Biopolis and across Singapore, as well as to obtain international recognition as a leading immunology research hub while establishing relationships with the best institutions in the world.
For more information about SIgN, please visit www.sign.a-star.edu.sg.
ANNEX A
LIST OF PROJECTS AWARDED
8th BMRC General Grant Call
S/N Project Title Principal
Investigator (PI)
Host
Institution
1 Development of andrographolide and its
derivatives for the treatment of allergic
asthma and asthma exacerbation
Wai Shiu Fred
Wong
NUS
2 Molecular characterization of cellular
receptor(s) and viral attachment domain of
Chikungunya virus: possible implications for
anti-viral therapy and vaccine development
Justin Chu Jang
Hann
NUS
3 Intrauterine gene therapy of haemophilia in a
non-human primate model
Jerry Chan NUS
4 Neurodegeneration in apolipoprotein E4
carriers: The regulation of mTOR1 by labile
zinc as a new mechanism of action
Barry Halliwell NUS
5 Discovering inhibitors against the Dengue
virus NS3 helicase and NS5 polymerase
using a fragment-based approach aided by
X-ray crystallography, N.M.R. and Surface
Plasmon resonance
Julien Lescar NTU
6 Virus-induced host cubic membranes: a novel
biomarker and target for understanding and
combating viral infections
Deng Yuru NUS
7 Functionalization of bioresorbable poly-
epsilon-caprolactone -20% tricalcium
phosphate cage devices to enhance delivery
of biological factors in interbody spine fusion
Wong Hee Kit NUS
8 New insight into liver fibrosis and hepatic
steatosis through label-free imaging using
multimodal nonlinear microscopy imaging
and Raman microspectroscopy at the
molecular and cellular levels
Huang Zhiwei NUS
9 A study to investigate the activation of a new
Akt/NHE-1 feedback loop in the redox
regulation of survival in normal and tumour
cells.
Marie-Veronique
Clement
NUS
10 Studies on the role of peptidyl-prolyl
isomerase Pin1 in regulating TR3-mediated
cell proliferation
Liou Yih Cherng NUS
11 Population coding in the primary visual cortex Yen Shih Cheng NUS
12 Elucidating specificity of BCH domains by
structural and functional characterization of
their complexes with RhoA and glutaminase
Sivaraman
Jayaraman
NUS
13 Ablation of alternatively spliced exon 33 of
Cav1.2 channel by genetic targeting in
mouse: implications in functions of
cardiovascular and nervous systems
Soong Tuck Wah NUS
14 Investigating the isoform-specific effects of
apolipoprotein E on N-methyl-D-aspartate
receptor (NMDAR) signalling during age-
related memory decline.
Wong Boon Seng NUS
15 Understanding the structure and assembly of
subunits E, F, G and a of nature’s most
versatile pump, V-ATPase
Gerhard Grüber NTU
16 An age-related neurodegeneration model in
Drosophila: establishment of links to lipid
metabolism and autophagy, and analysis of
lipidomic changes in sphingolipid and
cholesterol accumulation and trafficking
Rachel Kraut NTU
17 Exploring Wnt regulation in glioma-initiating
cells, and Wnt inhibition as a therapeutic
strategy
Carol Tang NNI
18 Mutation-resistant Antivirals James P. Tam NTU
19 Functional and structural characterization of
functional domains of the Reticulocyte
Binding Proteins of Plasmodium during
merozoite invasion
Peter Rainer
Preiser
NTU
20 Exploration of nuclear proteome for
chromatin remodelling proteins in the human
malaria parasites, Plasmodium falciparum
Zbynek Bozdech NTU
21 Interactions between stress and the serotonin
system in depression
Zhang Xiaodong Duke-NUS-
GMS
22 Genetic Markers of Retinal Vascular Calibre
and Cardiovascular Disease: The Singapore
Malay Eye Study & The Singapore
Prospective Study Programme
Wong Tien Yin SERI
23 Development and spatial expressions of
NR3B subunit in rat brain and functional
properties of Nr3B-containing N-methyl-D-
aspartate receptors
Low Chian-Ming NUS
24 Role of micoRNA in gastric cancer Richie Soong NUS
25 Revealing the structure and function of Orai1
and Stim1: the cause of severe combined
immune deficiency (SCID) syndrome
Said Eshaghi NTU
SIgN 2009 Collaborative Grant Call
S/N Project Title Extramural PI SIgN PI
1
Analysing the roles of CD137
ligand in macrophage polarisation and
myeloid leukemias
Herbert Schwarz
(NUS)
Philippe Kourilsky, Wong Siew Cheng
2
Development of fast response, sensitive
and selective biosensor probe system for
dengue and its serotypes for use at point-
of-cares in Singapore
Chee-Seng Toh
(NUS) Wang Cheng-I, Katja Fink
3
Understanding the innate immune
mechanism mediating human idiopathic
uveitis
Chee Soon Phaik
(Singapore
National Eye
Centre)
Subhra Biswas
4
Longitudinal analysis of the humoral
immune response of dengue patients from
the acute phase up to one year after
infection
Adrian Ong (Tan
Tock Seng
Hospital) Katja Fink